PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Allarity Therapeutics, Inc.
Filed: May 26, 2023
Period of Report: May 26, 2023
Accession Number: 0001213900-23-043573

View Document ↗ View on SEC.gov ↗